<DOC>
	<DOCNO>NCT00003749</DOCNO>
	<brief_summary>RATIONALE : Lymphadenectomy may remove cancer cell spread nearby lymph node . Radiation therapy use high-energy x-rays damage tumor cell . It yet know whether conventional surgery effective without lymphadenectomy and/or radiation therapy treat endometrial cancer . PURPOSE : Randomized phase III trial compare effectiveness conventional surgery without lymphadenectomy and/or radiation therapy treat patient endometrial cancer .</brief_summary>
	<brief_title>Surgery With Without Lymphadenectomy Radiation Therapy Treating Patients With Endometrial Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare effect conventional surgery alone conventional surgery plus lymphadenectomy patient endometrial cancer preoperatively think confine uterine corpus . - Determine effect postoperative adjuvant external beam radiotherapy quality life survival subset patient high risk relapse macroscopic disease surgery . OUTLINE : This randomize , multicenter study . Patients randomize surgery radiotherapy segment study . - Surgery : Patients randomize 1 2 surgery arm . - Arm I : Patients undergo conventional surgery ( total abdominal hysterectomy bilateral salpingo-oophorectomy ) . - Arm II : Patients undergo conventional surgery arm I follow lymphadenectomy systematic dissection iliac obturator node . - Radiotherapy : Patients high risk relapse postoperative macroscopic disease randomize 1 2 radiotherapy arm . ( Patients may enter radiotherapy randomization surgery study . ) - Arm I : Patients receive 20-25 fraction external beam radiotherapy ( total dose 40-46 Gy ) 4-5 week . - Arm II : Patients receive external beam radiotherapy . NOTE : Some patient receive vault brachytherapy regardless radiotherapy randomization . Quality life assess therapy 2 5 year therapy . Patients follow every 3 month 1 year every 6 month 1 year . PROJECTED ACCRUAL : A minimum 1400 patient accrued surgical component study least 900 patient ( include additional patient participate surgical component study ) accrue radiotherapy component study .</detailed_description>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Surgical randomization : Histologically confirm endometrial carcinoma Disease think preoperatively confine uterine corpus Radiotherapy randomization : Must disease determine postoperatively confine uterine corpus , irrespective pelvic node status No cervical stroma invasion ( stage IIB ) Must macroscopically free disease ( positive paraaortic node ) Must highrisk disease define one following : Grade 3 ( poorly differentiate ) Invasion outer half myometrium ( stage IC ) Serous papillary clear cell type Stage IIA ( endocervical glandular involvement ) PATIENT CHARACTERISTICS : Age : Any age Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No prior concurrent malignancy likely interfere protocol treatment comparison Surgical randomization : Must fit undergo lymphadenectomy external beam radiotherapy Radiotherapy randomization : Must fit receive external beam radiotherapy PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 1999</verification_date>
	<keyword>stage I endometrial carcinoma</keyword>
	<keyword>stage II endometrial carcinoma</keyword>
	<keyword>endometrial clear cell carcinoma</keyword>
	<keyword>endometrial papillary serous carcinoma</keyword>
</DOC>